Clinical Trials Directory

Trials / Unknown

UnknownNCT02810821

Gonadal Hormone, Gonadotropin and Cardiovascular Events

Association Between Serum Gonadal Hormone, Gonadotropin and Cardiovascular Events

Status
Unknown
Phase
Study type
Observational
Enrollment
8,000 (estimated)
Sponsor
Shandong Provincial Hospital · Other Government
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Accepted

Summary

Deficiency in gonadal hormone has been considered to play a role in ageing related increased incidence of cardiovascular events. But the mechanism has not been fully elucidated. On the other hand, the dramatic increase in gonadotropin level didn't drew much attention when talking about the increased risk of cardiovascular disease during menopausal transition. This study aim to investigate the association between gonadal hormone, gonadotropin and long-term cardiovascular events.

Conditions

Timeline

Start date
2011-07-01
Primary completion
2023-06-01
Completion
2023-06-01
First posted
2016-06-23
Last updated
2023-04-18

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT02810821. Inclusion in this directory is not an endorsement.

Gonadal Hormone, Gonadotropin and Cardiovascular Events (NCT02810821) · Clinical Trials Directory